These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9410899)

  • 1. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.
    Gahéry-Ségard H; Molinier-Frenkel V; Le Boulaire C; Saulnier P; Opolon P; Lengagne R; Gautier E; Le Cesne A; Zitvogel L; Venet A; Schatz C; Courtney M; Le Chevalier T; Tursz T; Guillet JG; Farace F
    J Clin Invest; 1997 Nov; 100(9):2218-26. PubMed ID: 9410899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
    Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene.
    van Ginkel FW; McGhee JR; Liu C; Simecka JW; Yamamoto M; Frizzell RA; Sorscher EJ; Kiyono H; Pascual DW
    J Immunol; 1997 Jul; 159(2):685-93. PubMed ID: 9218583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
    Sung RS; Qin L; Bromberg JS
    Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients.
    Griscelli F; Opolon P; Saulnier P; Mami-Chouaib F; Gautier E; Echchakir H; Angevin E; Le Chevalier T; Bataille V; Squiban P; Tursz T; Escudier B
    Gene Ther; 2003 Mar; 10(5):386-95. PubMed ID: 12601393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
    Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
    Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53).
    Yen N; Ioannides CG; Xu K; Swisher SG; Lawrence DD; Kemp BL; El-Naggar AK; Cristiano RJ; Fang B; Glisson BS; Hong WK; Khuri FR; Kurie JM; Lee JJ; Lee JS; Merritt JA; Mukhopadhyay T; Nesbitt JC; Nguyen D; Perez-Soler R; Pisters KM; Putnam JB; Schrump DS; Shin DM; Walsh GL; Roth JA
    Cancer Gene Ther; 2000 Apr; 7(4):530-6. PubMed ID: 10811470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cellular immune responses in rhesus monkeys subjected to adenovirus-mediated gene transfer into the cervix.
    Sarkar AK; Mitchell MF; Hamada K; Buchl SJ; Satterfield WC; Schapiro SJ; Keeling ME; Sastry KJ
    Cancer Gene Ther; 1999; 6(3):220-7. PubMed ID: 10359207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial.
    Stewart AK; Lassam NJ; Quirt IC; Bailey DJ; Rotstein LE; Krajden M; Dessureault S; Gallinger S; Cappe D; Wan Y; Addison CL; Moen RC; Gauldie J; Graham FL
    Gene Ther; 1999 Mar; 6(3):350-63. PubMed ID: 10435085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.
    Lee MG; Abina MA; Haddada H; Perricaudet M
    Gene Ther; 1995 Jun; 2(4):256-62. PubMed ID: 7552985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model.
    Li Z; Rakkar A; Katayose Y; Kim M; Shanmugam N; Srivastava S; Moul JW; McLeod DG; Cowan KH; Seth P
    Gene Ther; 1998 May; 5(5):605-13. PubMed ID: 9797864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.
    Harvey BG; Hackett NR; Ely S; Crystal RG
    Mol Ther; 2001 Feb; 3(2):206-15. PubMed ID: 11237677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
    Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
    Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
    Parks R; Evelegh C; Graham F
    Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer.
    van der Linden RR; Haagmans BL; Mongiat-Artus P; van Doornum GJ; Kraaij R; Kadmon D; Aguilar-Cordova E; Osterhaus AD; van der Kwast TH; Bangma CH
    Eur Urol; 2005 Jul; 48(1):153-61. PubMed ID: 15967266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
    Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
    Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adenovirus administration in rat peritoneum: endothelial expression and safety concerns.
    Martin-Martinez MD; Stoenoiu M; Verkaeren C; Devuyst O; Delporte C
    Nephrol Dial Transplant; 2004 May; 19(5):1293-7. PubMed ID: 14993505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system.
    Zou L; Zhou H; Pastore L; Yang K
    Mol Ther; 2000 Aug; 2(2):105-13. PubMed ID: 10947937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.